Alternative Networks (AN.)

   Trade now with Barclays Stockbrokers   Trade now with Barclays   Sponsored by Barclays Stockbrokers

 424.75p
   
  • Change Today:
      0.000p
  • 52 Week High: 585.50
  • 52 Week Low: 338.50
  • Currency: UK Pounds
  • Shares Issued: 48.36m
  • Volume: 500
  • Market Cap: £205.40m
  • RiskGrade: 138
  • Beta: 0.02

Non-exec buys after Smiths rejects approach for division

Date: Thursday 20 Jan 2011

LONDON (ShareCast) - Bruno Angelici, a non-executive director of Smiths Group, has bought his first shares in the company less than a week after it was revealed that the technology supplier had rejected an approach for its medical division.

Angelici paid 1392p a share for the 2,000 shares he acquired – a total outlay of nearly £28,000. The share price closed at 1283p on 13 January – the day before the approach was revealed.

Angelici joined the Smiths board in July 2010. The French man is a former executive of AstraZeneca and he was received into the Legion d’honneur in December 2009.

Smiths rejected a £2.45bn approach for its biggest division Smiths Medical. It said it had carefully considered the approach, which came from the private equity group Apax according to media reports, concluding that continuing discussions on the basis of a sale at that level would not be in shareholders’ best interests.

Smiths Medical accounted for about 31% of the company’s sales last year.

Research company Edison Investment, however, expects Smiths to be broken up at some point. “We feel that it is only a matter of time before a satisfactory bid will kick-start the process,” Edison said.

Smiths is expected to announce its interim results on 23 March.


Top Director Buys

Smiths Group (SMIN)
Director name: Mr Bruno Angelici
Amount purchased: 2,000 @ 1,392.00p
Value: £27,840

Midas Income & Growth Trust (MIGT)
Director name: Mr Hubert Reid
Amount purchased: 18,868 @ 116.50p
Value: £21,981

ViCTory VCT (VICT)
Director name: Mr Christopher Moorsom
Amount purchased: 43,000 @ 38.00p
Value: £16,340

Elektron (EKT)
Director name: Mr Jeremy Gordon Thorn
Amount purchased: 38,000 @ 40.60p
Value: £15,428

Elektron (EKT)
Director name: Mr Jeremy Gordon Thorn
Amount purchased: 38,000 @ 40.60p
Value: £15,428

ViCTory VCT (VICT)
Director name: Mr David M Page
Amount purchased: 32,620 @ 38.00p
Value: £12,396


Top Director Sells

Cairn Energy (CNE)
Director name: Mr Malcolm Thoms
Amount sold: 212,300 @ 448.09p
Value: £951,295

Cairn Energy (CNE)
Director name: Mr Philip Tracy
Amount sold: 141,534 @ 448.09p
Value: £634,200

Alternative Networks (AN.)
Director name: Mr Edward Spurrier
Amount sold: 300,000 @ 190.00p
Value: £570,000

Cairn Energy (CNE)
Director name: Sir Bill Gammell
Amount sold: 116,371 @ 448.09p
Value: £521,447

Alternative Networks (AN.)
Director name: Mr James Murray
Amount sold: 250,000 @ 190.00p
Value: £475,000

Bankers Petroleum Ltd. (BNK)
Director name: Mr Eric M Brown
Amount sold: 50,000 @ 552.47p
Value: £276,235

Alternative Networks (AN.)
Director name: Mr Benjamin Marnham
Amount sold: 225,000 @ 190.00p
Value: £427,500

Next (NXT)
Director name: Mr C E Angelides
Amount sold: 18,953 @ 2,148.00p
Value: £407,110

Cairn Energy (CNE)
Director name: Dr Mike J Watts
Amount sold: 82,561 @ 448.09p
Value: £369,948

Cairn Energy (CNE)
Director name: Mrs Janice Margaret Brown
Amount sold: 60,610 @ 448.09p
Value: £271,587

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

AN. Market Data

Currency UK Pounds
Share Price 424.75p
Change Today 0.000p
% Change 0.00 %
52 Week High 585.50
52 Week Low 338.50
Volume 500
Shares Issued 48.36m
Market Cap £205.40m
Beta 0.02
RiskGrade 138

AN. Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
76.77% below the market average76.77% below the market average76.77% below the market average76.77% below the market average76.77% below the market average
85.71% below the sector average85.71% below the sector average85.71% below the sector average85.71% below the sector average85.71% below the sector average
Price Trend
67.36% above the market average67.36% above the market average67.36% above the market average67.36% above the market average67.36% above the market average
86.67% above the sector average86.67% above the sector average86.67% above the sector average86.67% above the sector average86.67% above the sector average
Income
37.80% above the market average37.80% above the market average37.80% above the market average37.80% above the market average37.80% above the market average
60% below the sector average60% below the sector average60% below the sector average60% below the sector average60% below the sector average
Growth
42.92% below the market average42.92% below the market average42.92% below the market average42.92% below the market average42.92% below the market average
9.09% above the sector average9.09% above the sector average9.09% above the sector average9.09% above the sector average9.09% above the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 1
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

AN. Dividends

  Latest Previous
  Interim Final
Ex-Div 25-Jun-14 18-Dec-13
Paid 18-Jul-14 31-Jan-14
Amount 4.90p 8.60p

Trades for 21-Oct-2014

Time Volume / Share Price
08:14 500 @ 422.00p

AN. Key Personnel

CEO Edward Spurrier
CFO Gavin Griggs

Top of Page